Cargando…
Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
BACKGROUND: Melanoma, the most aggressive form of skin cancer, is characterized by high rates of metastasis, drug resistance and mortality. Here we investigated the role of Semaphorin 5A (Sema5A) on the properties associated with melanoma progression and the factors involved in Sema5A regulation. ME...
Autores principales: | D’Aguanno, Simona, Valentini, Elisabetta, Tupone, Maria Grazia, Desideri, Marianna, Di Martile, Marta, Spagnuolo, Manuela, Buglioni, Simonetta, Ercolani, Cristiana, Falcone, Italia, De Dominici, Marco, Milella, Michele, Rizzo, Maria Giulia, Calabretta, Bruno, Cota, Carlo, Anichini, Andrea, Trisciuoglio, Daniela, Del Bufalo, Donatella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245779/ https://www.ncbi.nlm.nih.gov/pubmed/30454024 http://dx.doi.org/10.1186/s13046-018-0933-x |
Ejemplares similares
-
SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
por: Valentini, Elisabetta, et al.
Publicado: (2021) -
BCL-X(L) overexpression promotes tumor progression-associated properties
por: Trisciuoglio, Daniela, et al.
Publicado: (2017) -
microRNA-378a-5p iS a novel positive regulator of melanoma progression
por: Tupone, Maria Grazia, et al.
Publicado: (2020) -
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
por: Di Martile, Marta, et al.
Publicado: (2020) -
Affinity purification-mass spectrometry analysis of bcl-2 interactome identified SLIRP as a novel interacting protein
por: Trisciuoglio, D, et al.
Publicado: (2016)